83 related articles for article (PubMed ID: 1316100)
1. [Randomized trial-comparing UFT and FT in the treatment of advanced hepatocellular carcinoma (second report: well controlled study on patients with transcatheter arterial embolization) Osaka Research Society for Liver, Gallbladder and Pancreas].
Kojima J; Kamata T; Monna T
Gan To Kagaku Ryoho; 1992 May; 19(5):637-46. PubMed ID: 1316100
[TBL] [Abstract][Full Text] [Related]
2. [Randomized trial comparing UFT and FT-207 in the treatment of advanced hepatocellular carcinoma (first report: well controlled study on the patients for whom transcatheter arterial embolization could not be applied) Osaka Research Society for Liver, Gallbladder and Pancreas].
Kojima J; Kamata T; Monna T
Gan To Kagaku Ryoho; 1990 May; 17(5):1005-13. PubMed ID: 2159264
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Kitamura T; Maruyama T; Nakamura H; Hayashi K; Shigehira M; Iwaki Y; Okamoto T; Ishikawa T; Ishinoda Y; Kisanuki H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1467-71. PubMed ID: 2167633
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
[TBL] [Abstract][Full Text] [Related]
5. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Ohmura K; Suzuki M; Takao ; Matsuo SK; Ohtsuka Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):523-6. PubMed ID: 3028278
[TBL] [Abstract][Full Text] [Related]
7. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
Lu W; Li Y; He X; Chen Y
Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
[TBL] [Abstract][Full Text] [Related]
9. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
11. [Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Sawada Y; Iwamoto S; Yurino N; Fujii S; Murai N; Okuno F; Kotake H; Mashiba H
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2471-5. PubMed ID: 1659329
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
Shi Z; Guo Y; Liu D
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer.
Chen HB; Huang Y; Dai DL; Zhang X; Huang ZW; Zhang QK; Wang HH; Zhang JS; Pan G
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):55-7. PubMed ID: 14969838
[TBL] [Abstract][Full Text] [Related]
14. [Maintenance chemotherapy by UFT after trans-arterial embolization for hepatocellular carcinoma].
Nakanishi T; Kawakami H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1589-95. PubMed ID: 3015034
[TBL] [Abstract][Full Text] [Related]
15. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.
Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R
Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
Takashima S; Tomita F; Saito H; Gotoda H; Kinami Y; Miyazaki I; Yamaguchi A
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2315-24. PubMed ID: 1929450
[TBL] [Abstract][Full Text] [Related]
17. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
[TBL] [Abstract][Full Text] [Related]
19. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
[TBL] [Abstract][Full Text] [Related]
20. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
Tashiro H; Nomura Y; Ohsaki A
Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
